Oncology & Cancer

Aspirin may cut mortality in nonmetastatic prostate cancer

(HealthDay)—Daily aspirin use, even at low doses, may reduce mortality among men with high-risk nonmetastatic prostate cancer, according to research published online Oct. 20 in the Journal of Clinical Oncology.

Oncology & Cancer

Benefit of aggressive prostate CA Tx weakens as comorbidity rises

(HealthDay)—For men with early-stage prostate cancer, the cancer-specific survival benefit associated with aggressive prostate cancer treatment is reduced with increasing comorbidity, according to a study published online ...

Oncology & Cancer

Clinical trials show promise for prostate cancer drug

A 30 percent reduction in mortality risk is one of the impressive results achieved in a global clinical drug trial for the treatment of prostate cancer. The full trial data are due to be presented today at one of the world´s ...

page 5 from 8